Acquiring Company
London Stock Exchange Group plc (LSEG)
Acquired Company
Ellipses Pharma Limited
Description
Ellipses Pharma is pursuing a London listing through a reverse takeover deal. The text is largely boilerplate disclaimers from Global Banking & Finance Review and does not identify the acquiring company or give deal terms.
Quick answer
London Stock Exchange Group plc (LSEG) is acquiring Ellipses Pharma Limited, announced November 18, 2026. London Stock Exchange Group plc (LSEG) is based in New York, New York, United States.
- How much did London Stock Exchange Group plc (LSEG) pay for Ellipses Pharma Limited?
- The deal value was not disclosed.
- What does London Stock Exchange Group plc (LSEG) do?
- London Stock Exchange Group plc (LSEG) is a leading financial infrastructure and capital markets business, operating a broad range of international equity, bond and derivatives markets.
- Where are London Stock Exchange Group plc (LSEG) and Ellipses Pharma Limited based?
- London Stock Exchange Group plc (LSEG) is based in New York, New York, United States. Ellipses Pharma Limited is based in United Arab Emirates.
Source: Fundz verified event record.
Other recent acquisitions in Financial Services and Finance
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Nuformix proposes merger with Biovara (November 11, 2026)
- Acrivon Therapeutics Acquires Aqilion’s Drug Development Programs (November 6, 2026)
- Indivior Pharmaceuticals Completes Acquisition of Supernus Pharmaceuticals (November 2, 2026)
- Abeona Therapeutics to Acquire APT-1011 Assets from Ellodi Pharmaceuticals (November 9, 2026)
- Petauri acquires Franklin Pharmaceutical Consulting (October 8, 2026)
- Everis Medical combines with Hemostasis (November 17, 2026)
Who to call at London Stock Exchange Group plc (LSEG), and when
When London Stock Exchange Group plc (LSEG) changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day London Stock Exchange Group plc (LSEG) raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at London Stock Exchange Group plc (LSEG), from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at London Stock Exchange Group plc (LSEG). With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment London Stock Exchange Group plc (LSEG) makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Ellipses Pharma Limited?
Ellipses Pharma Limited was acquired by London Stock Exchange Group plc (LSEG), based in New York. The deal was reported on November 18, 2026. London Stock Exchange Group plc (LSEG) is a leading financial infrastructure and capital markets business, operating a broad range of international equity, bond and derivatives markets. London Stock Exchange Group plc (LSEG) is privately held and operates in Financial Services.
When did London Stock Exchange Group plc (LSEG) acquire Ellipses Pharma Limited?
London Stock Exchange Group plc (LSEG)'s acquisition of Ellipses Pharma Limited was reported on November 18, 2026. Ellipses Pharma is pursuing a London listing through a reverse takeover deal. The text is largely boilerplate disclaimers from Global Banking & Finance Review and does not identify the acquiring company or give deal terms. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Ellipses Pharma Limited do?
Ellipses Pharma Limited is a global drug development company focused on accelerating the development of cancer treatments through an innovative drug development model. It is privately held, operating in Biotechnology, and is based in United Arab Emirates.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.